Suppr超能文献

利用具有有效直接病毒杀灭和抗 HCV 和 HSV 复制潜力的 Natrialba sp. M6 生产生物表面活性剂的生物工艺开发。

Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV.

机构信息

National Institute of Oceanography & Fisheries, NIOF-Egypt, Qaitbay Sq, El-Anfousy, Alexandria, 11865, Egypt.

Medical Biotechnology Department, Genetic Engineering & Biotechnology Research Institute (GEBRI), City of Scientific Research & Technological Applications, Alexandria, Egypt.

出版信息

Sci Rep. 2022 Oct 4;12(1):16577. doi: 10.1038/s41598-022-20091-0.

Abstract

Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and identified using GC-Mass spectrometry. Sequential optimization approaches, Plackett-Burman (PB) and Box-Behnken Designs (BBD) were applied to maximize the biosurfactants production from M6 strain by using 14 factors; pH, NaCl, agitation and glycerol; the most significant factors that influenced the biosurfactant production were used for Response Surface Methodology (RSM). The final optimal production conditions were agitation (150 rpm), glycerol (3%), NaCl (20.8%), pH (12) and cultivation temperature (37°C). GC-Mass spectrometry for the recovered extract revealed the presence of a diverse group of bipolar nature, hydrophobic hydrocarbon chain and charged function group. The majority of these compounds are fatty acids. Based on results of GC-MS, compositional analysis content and Zetasizer, it was proposed that the extracted biosurfactant produced by haloarchaeon Natrialba sp. M6 could be a cationic lipoprotein. The antiviral activity of such biosurfactant was investigated against hepatitis C (HCV) and herpes simplex (HSV1) viruses at its maximum safe doses (20 μg/mL and 8 μg/mL, respectively). Its mode of antiviral action was declared to be primarily via deactivating viral envelopes thus preventing viral entry. Moreover, this biosurfactant inhibited RNA polymerase- and DNA polymerase-mediated viral replication at IC of 2.28 and 4.39 μg/mL, respectively also. Molecular docking studies showed that surfactin resided well and was bound to the specified motif with low and accepted binding energies (ΔG = - 5.629, - 6.997 kcal/mol) respectively. Therefore, such biosurfactant could be presented as a natural safe and effective novel antiviral agent.

摘要

嗜盐古菌被认为是许多重要代谢物的有前途的天然来源。本研究专注于一种由嗜盐古菌 Natrialba sp. M6 产生的表面活性生物分子,称为生物表面活性剂。使用 GC-Mass 光谱法优化了生产趋势,并对产物进行了部分纯化和鉴定。连续优化方法,Plackett-Burman(PB)和 Box-Behnken 设计(BBD)用于通过使用 14 个因素最大限度地提高 M6 菌株的生物表面活性剂产量; pH、NaCl、搅拌和甘油;影响生物表面活性剂产量的最重要因素用于响应面法(RSM)。最终的最佳生产条件是搅拌(150 rpm)、甘油(3%)、NaCl(20.8%)、pH(12)和培养温度(37°C)。回收提取物的 GC-Mass 光谱显示存在一组具有双极性、疏水性烃链和带电功能基团的不同化合物。这些化合物中的大多数是脂肪酸。基于 GC-MS 的结果、组成分析含量和 Zetasizer,提出由嗜盐古菌 Natrialba sp. M6 产生的提取生物表面活性剂可能是一种阳离子脂蛋白。在最大安全剂量(分别为 20 μg/mL 和 8 μg/mL)下,研究了该生物表面活性剂对丙型肝炎(HCV)和单纯疱疹(HSV1)病毒的抗病毒活性。其抗病毒作用模式被宣布主要是通过使病毒包膜失活从而阻止病毒进入。此外,该生物表面活性剂还抑制 RNA 聚合酶和 DNA 聚合酶介导的病毒复制,IC 分别为 2.28 和 4.39 μg/mL。分子对接研究表明,表面活性剂很好地驻留并与指定基序结合,具有低且可接受的结合能(ΔG=-5.629,-6.997 kcal/mol)。因此,这种生物表面活性剂可以作为一种天然的安全有效的新型抗病毒药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd1/9532386/a12346193b37/41598_2022_20091_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验